Nucleus Accumbens Medium Spiny Neuron Subtypes Differentially Regulate Stress-Associated Alterations in Sleep Architecture

[1]  J. Calabrese,et al.  Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) , 2020, Neuropsychopharmacology.

[2]  J. Calabrese,et al.  A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia , 2020, Nature Medicine.

[3]  J. Kanady,et al.  Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms , 2019, Neuropsychopharmacology.

[4]  B. Jones.  Arousal and sleep circuits , 2019, Neuropsychopharmacology.

[5]  M. Lobo,et al.  Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress , 2019, Neuropsychopharmacology.

[6]  D. Riemann,et al.  Sleep, insomnia, and depression , 2019, Neuropsychopharmacology.

[7]  K. Ressler,et al.  The critical importance of basic animal research for neuropsychiatric disorders , 2019, Neuropsychopharmacology.

[8]  M. Lobo,et al.  The molecular and cellular mechanisms of depression: a focus on reward circuitry , 2019, Molecular Psychiatry.

[9]  S. Fujii,et al.  Acute Social Defeat Stress Increases Sleep in Mice , 2019, Front. Neurosci..

[10]  M. Michaelides,et al.  Nucleus Accumbens Drd1-Expressing Neurons Control Aggression Self-Administration and Aggression Seeking in Mice , 2019, The Journal of Neuroscience.

[11]  C. McDougle,et al.  Sex-dependent neurobiological features of prenatal immune activation via TLR7 , 2019, Molecular Psychiatry.

[12]  L. de Lecea,et al.  In vivo cell type-specific CRISPR knockdown of dopamine beta hydroxylase reduces locus coeruleus evoked wakefulness , 2018, Nature Communications.

[13]  S. Rauch,et al.  Digital devices and continuous telemetry: opportunities for aligning psychiatry and neuroscience , 2018, Neuropsychopharmacology.

[14]  Zhi-Li Huang,et al.  Nucleus accumbens controls wakefulness by a subpopulation of neurons expressing dopamine D1 receptors , 2018, Nature Communications.

[15]  C. McDougle,et al.  Maternal and Early Postnatal Immune Activation Produce Dissociable Effects on Neurotransmission in mPFC–Amygdala Circuits , 2018, The Journal of Neuroscience.

[16]  C. McDougle,et al.  Perinatal Immune Activation Produces Persistent Sleep Alterations and Epileptiform Activity in Male Mice , 2018, Neuropsychopharmacology.

[17]  S. Russo,et al.  Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibility , 2018, Proceedings of the National Academy of Sciences.

[18]  K. Ressler,et al.  Cell-type-specific interrogation of CeA Drd2 neurons to identify targets for pharmacological modulation of fear extinction , 2017, bioRxiv.

[19]  S. Schiffmann,et al.  Striatal adenosine A2A receptor neurons control active-period sleep via parvalbumin neurons in external globus pallidus , 2017, eLife.

[20]  E. Nestler,et al.  Establishment of a repeated social defeat stress model in female mice , 2017, Scientific Reports.

[21]  S. Schiffmann,et al.  Slow-wave sleep is controlled by a subset of nucleus accumbens core neurons in mice , 2017, Nature Communications.

[22]  B. Cohen,et al.  Effects of Chronic Social Defeat Stress on Sleep and Circadian Rhythms Are Mitigated by Kappa-Opioid Receptor Antagonism , 2017, The Journal of Neuroscience.

[23]  Brandon K. Harvey,et al.  Chemogenetics revealed: DREADD occupancy and activation via converted clozapine , 2017, Science.

[24]  E. Nestler,et al.  Early life stress confers lifelong stress susceptibility in mice via ventral tegmental area OTX2 , 2017, Science.

[25]  W. A. Carlezon Jr.,et al.  Behavioral methods to study anxiety in rodents , 2017, Dialogues in clinical neuroscience.

[26]  Lina M. Tran,et al.  Chemogenetic Interrogation of a Brain-wide Fear Memory Network in Mice , 2017, Neuron.

[27]  M. Lobo,et al.  Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression , 2017, Biological Psychiatry.

[28]  A. Bonci,et al.  Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity , 2017, Neuron.

[29]  K. Ressler,et al.  Molecular characterization of Thy1 expressing fear-inhibiting neurons within the basolateral amygdala , 2016, Nature Communications.

[30]  A. Krystal,et al.  Kappa‐Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials , 2016, Depression and anxiety.

[31]  L. Lecea,et al.  VTA dopaminergic neurons regulate ethologically relevant sleep–wake behaviors , 2016, Nature Neuroscience.

[32]  N. Sousa,et al.  Reappraising striatal D1- and D2-neurons in reward and aversion , 2016, Neuroscience & Biobehavioral Reviews.

[33]  W. Carlezon,et al.  Use of Adeno‐Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice , 2015, Current protocols in neuroscience.

[34]  S. Russo,et al.  Anhedonia and the Brain Reward Circuitry in Depression , 2015, Current Behavioral Neuroscience Reports.

[35]  K. Deisseroth,et al.  Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression , 2015, Nature Communications.

[36]  Robert M Sears,et al.  Active Avoidance Requires a Serial Basal Amygdala to Nucleus Accumbens Shell Circuit , 2015, The Journal of Neuroscience.

[37]  Alexxai V. Kravitz,et al.  Nucleus Accumbens Medium Spiny Neuron Subtypes Mediate Depression-Related Outcomes to Social Defeat Stress , 2015, Biological Psychiatry.

[38]  E. Nestler,et al.  β-catenin mediates behavioral resilience through Dicer1/microRNA regulation , 2014, Nature.

[39]  E. Nestler,et al.  Effects of Striatal ΔFosB Overexpression and Ketamine on Social Defeat Stress–Induced Anhedonia in Mice , 2014, Biological Psychiatry.

[40]  J. Moctezuma,et al.  Update of sleep alterations in depression , 2014, Sleep science.

[41]  Raag D. Airan,et al.  Natural Neural Projection Dynamics Underlying Social Behavior , 2014, Cell.

[42]  E. Nestler,et al.  G9a influences neuronal subtype specification in striatum , 2014, Nature Neuroscience.

[43]  S. Lammel,et al.  Reward and aversion in a heterogeneous midbrain dopamine system , 2014, Neuropharmacology.

[44]  A. Gemignani,et al.  REM sleep dysregulation in depression: state of the art. , 2013, Sleep medicine reviews.

[45]  K. Berridge.  Faculty Opinions recommendation of Differential innervation of direct- and indirect-pathway striatal projection neurons. , 2013 .

[46]  Scott J. Russo,et al.  The brain reward circuitry in mood disorders , 2013, Nature Reviews Neuroscience.

[47]  Robert C. Malenka,et al.  Anhedonia requires MC4 receptor-mediated synaptic adaptations in nucleus accumbens , 2012, Nature.

[48]  N. Kronfeld-Schor,et al.  Circadian rhythms and depression: Human psychopathology and animal models , 2012, Neuropharmacology.

[49]  C. Gerfen,et al.  Modulation of striatal projection systems by dopamine. , 2011, Annual review of neuroscience.

[50]  E. Meloni,et al.  Activation of CREB in the Nucleus Accumbens Shell Produces Anhedonia and Resistance to Extinction of Fear in Rats , 2011, The Journal of Neuroscience.

[51]  Deanna L. Wallace,et al.  ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses , 2010, Nature Neuroscience.

[52]  A. Steiger,et al.  Wake and sleep EEG provide biomarkers in depression. , 2010, Journal of psychiatric research.

[53]  Mark J. Thomas,et al.  Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis , 2009, Neuropharmacology.

[54]  Jean-Michel Deniau,et al.  Striatal Medium-Sized Spiny Neurons: Identification by Nuclear Staining and Study of Neuronal Subpopulations in BAC Transgenic Mice , 2009, PloS one.

[55]  Deanna L. Wallace,et al.  CREB regulation of nucleus accumbens excitability mediates social isolation–induced behavioral deficits , 2009, Nature Neuroscience.

[56]  Anatol C. Kreitzer,et al.  Striatal Plasticity and Basal Ganglia Circuit Function , 2008, Neuron.

[57]  D. Nutt,et al.  Sleep disorders as core symptoms of depression , 2008, Dialogues in clinical neuroscience.

[58]  E. Meloni,et al.  Anxiolytic-Like Effects of κ-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[59]  Scott J. Russo,et al.  Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions , 2007, Cell.

[60]  E. Nestler,et al.  The Mesolimbic Dopamine Reward Circuit in Depression , 2006, Biological Psychiatry.

[61]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[62]  Eric J. Nestler,et al.  New approaches to antidepressant drug discovery: beyond monoamines , 2006, Nature Reviews Neuroscience.

[63]  Cécile Béguin,et al.  Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[64]  Karen Ritchie,et al.  Sleep and depression. , 2005, The Journal of clinical psychiatry.

[65]  Philip S. Portoghese,et al.  Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[66]  E. Nestler,et al.  Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens , 2001, The Journal of Neuroscience.

[67]  A. John Rush,et al.  Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls , 2000, Psychiatry Research.

[68]  N. Hiroi,et al.  Region‐specific induction of ΔFosB by repeated administration of typical versus atypical antipsychotic drugs , 1999, Synapse.

[69]  V. Pickel,et al.  Cellular Sites for Dynorphin Activation of κ-Opioid Receptors in the Rat Nucleus Accumbens Shell , 1999, The Journal of Neuroscience.

[70]  N. Hiroi,et al.  Regulation of cocaine reward by CREB. , 1998, Science.

[71]  R. Wise,et al.  Rewarding Actions of Phencyclidine and Related Drugs in Nucleus Accumbens Shell and Frontal Cortex , 1996, The Journal of Neuroscience.

[72]  M. Candito,et al.  Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality , 1989, Psychiatry Research.

[73]  A. Rush,et al.  Clinical predictors of recurrence in depression. , 1989, The American journal of psychiatry.

[74]  A. Rush,et al.  Reduced REM latency predicts response to tricyclic medication in depressed outpatients , 1989, Biological Psychiatry.

[75]  A. Rush,et al.  Reduced rapid eye movement latency. A predictor of recurrence in depression. , 1987, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[76]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[77]  Zachary S. Lorsch,et al.  In Vivo Fiber Photometry Reveals Signature of Future Stress Susceptibility in Nucleus Accumbens , 2018, Neuropsychopharmacology.

[78]  E. Nestler,et al.  Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress , 2018, Neuropsychopharmacology.

[79]  W. Duncan,et al.  Circadian rhythms and the pharmacology of affective illness. , 1996, Pharmacology & therapeutics.

[80]  Comments on posttraumatic stress disorder. , 1989, The American journal of psychiatry.